Cartesian Therapeutics, Inc. — Director's Dealing 2020

Aug 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-08-01

Reporting Person: TRABER PETER G (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-01	Employee Stock Option (right to buy)	$2.38	A	650000	Acquired	2030-07-31	Common Stock (650000.0)	Direct

Footnotes

F1: This option will vest as to 25% on August 1, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.